BARIUM SULFATE Pharmacologic Class Indexing
- Class set ID
- c311a62c-dd7a-4dd2-b953-1e0728ec4d14
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use ENTERO VU 24% safely and effectively. See full prescribing information for ENTERO VU 24%. ENTERO VU 24% (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260515 | 7 |
| These highlights do not include all the information needed to use VARIBAR NECTAR safely and effectively. See full prescribing information for VARIBAR NECTAR. VARIBAR NECTAR (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260515 | 9 |
| These highlights do not include all the information needed to use VARIBAR PUDDING safely and effectively. See full prescribing information for VARIBAR PUDDING. VARIBAR PUDDING (barium sulfate) oral paste Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260515 | 9 |
| These highlights do not include all the information needed to use VARIBAR THIN HONEY safely and effectively. See full prescribing information for VARIBAR THIN HONEY. VARIBAR THIN HONEY (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260515 | 8 |
| These highlights do not include all the information needed to use E-Z-HD safely and effectively. See full prescribing information for E-Z-HD. E-Z-HD (barium sulfate) for oral suspension, Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | CIMBAR PERFORMANCE MINERALS, INC. | 20260415 | 8 |
| These highlights do not include all the information needed to use E-Z-PAQUE safely and effectively. See full prescribing information for E-Z-PAQUE. E-Z-PAQUE (barium sulfate) for oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260415 | 6 |
| These highlights do not include all the information needed to use Liquid E-Z-PAQUE safely and effectively. See full prescribing information for Liquid E-Z-PAQUE. Liquid E-Z-PAQUE (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260415 | 8 |
| These highlights do not include all the information needed to use READI-CAT 2 and READI-CAT 2 SMOOTHIE products safely and effectively. See full prescribing information for READI-CAT 2 (barium sulfate) oral suspension READI-CAT 2 SMOOTHIE (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260415 | 4 |
| These highlights do not include all the information needed to use TAGITOL V safely and effectively. See full prescribing information for TAGITOL V. TAGITOL V (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260415 | 6 |
| These highlights do not include all the information needed to use VARIBAR THIN LIQUID safely and effectively. See full prescribing information for VARIBAR THIN LIQUID. VARIBAR THIN LIQUID (barium sulfate) for oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20260415 | 7 |
| NDC 32909-770-01 E-Z-PASTE ® BARIUM SULFATE ESOPHAGEAL CREAM (60% w/w) | E-Z-EM Canada Inc | E-Z-EM, INC. | 20251218 | 4 |
| These highlights do not include all the information needed to use VARIBAR HONEY safely and effectively. See full prescribing information for VARIBAR HONEY. VARIBAR HONEY (barium sulfate) oral suspension Initial U.S. Approval: 2016 | E-Z-EM Canada Inc | BRACCO DIAGNOSTICS INC | 20251215 | 6 |
| These highlights do not include all the information needed to use E-Z-DISK safely and effectively. See full prescribing information for E-Z-DISK. E-Z-DISK (barium sulfate) tablets, for oral use Initial U.S. Approval: 2016 | E-Z-EM, INC. | Bracco Diagnostics Inc | Confab Laboratories Inc | E-Z-EM Canada Inc | 20250929 | 10 |
| These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval. | Vizumax Diagnostics LLC | 20211004 | 4 |
| These highlights do not include all the information needed to use, see full prescribing information for additional details. Initial U.S. Approval. | Vizumax Diagnostics LLC | 20211004 | 11 |
| 05f1030d-1a9c-05df-e054-00144ff8d46c | Genus Medical Technologies, LLC | 20210111 | 4 |
| Vanilla SilQ HD | Genus Medical Technologies, LLC | 20210111 | 4 |
| Vanilla SilQ MD (R) | Genus Medical Technologies, LLC | 20210111 | 4 |